Literature DB >> 18510945

PI3K signaling supports amphetamine-induced dopamine efflux.

Brandon J Lute1, Habibeh Khoshbouei, Christine Saunders, Namita Sen, Richard Z Lin, Jonathan A Javitch, Aurelio Galli.   

Abstract

The dopamine (DA) transporter (DAT) is a major molecular target of the psychostimulant amphetamine (AMPH). AMPH, as a result of its ability to reverse DAT-mediated inward transport of DA, induces DA efflux thereby increasing extracellular DA levels. This increase is thought to underlie the behavioral effects of AMPH. We have demonstrated previously that insulin, through phosphatidylinositol 3-kinase (PI3K) signaling, regulates DA clearance by fine-tuning DAT plasma membrane expression. PI3K signaling may represent a novel mechanism for regulating DA efflux evoked by AMPH, since only active DAT at the plasma membrane can efflux DA. Here, we show in both a heterologous expression system and DA neurons that inhibition of PI3K decreases DAT cell surface expression and, as a consequence, AMPH-induced DA efflux.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18510945      PMCID: PMC2517853          DOI: 10.1016/j.bbrc.2008.05.091

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat.

Authors:  D P Figlewicz; S B Evans; J Murphy; M Hoen; D G Baskin
Journal:  Brain Res       Date:  2003-02-21       Impact factor: 3.252

Review 2.  Molecular characterization of the dopamine transporter.

Authors:  B Giros; M G Caron
Journal:  Trends Pharmacol Sci       Date:  1993-02       Impact factor: 14.819

3.  Characterization of genetically labeled catecholamine neurons in the mouse retina.

Authors:  Dao-Qi Zhang; Jeffrey F Stone; Tongrong Zhou; Hidenobu Ohta; Douglas G McMahon
Journal:  Neuroreport       Date:  2004-08-06       Impact factor: 1.837

4.  Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism.

Authors:  Habibeh Khoshbouei; Hongwei Wang; James D Lechleiter; Jonathan A Javitch; Aurelio Galli
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

5.  Steady states, charge movements, and rates for a cloned GABA transporter expressed in Xenopus oocytes.

Authors:  S Mager; J Naeve; M Quick; C Labarca; N Davidson; H A Lester
Journal:  Neuron       Date:  1993-02       Impact factor: 17.173

6.  Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier.

Authors:  Kristopher M Kahlig; Jonathan A Javitch; Aurelio Galli
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

7.  PI 3-kinase regulation of dopamine uptake.

Authors:  Lucia Carvelli; José A Morón; Kristopher M Kahlig; Jasmine V Ferrer; Namita Sen; James D Lechleiter; L M Fredrik Leeb-Lundberg; Gerald Merrill; Eileen M Lafer; Lisa M Ballou; Toni S Shippenberg; Jonathan A Javitch; Richard Z Lin; Aurelio Galli
Journal:  J Neurochem       Date:  2002-05       Impact factor: 5.372

8.  Stereotyped behavior and diabetes mellitus in rats: reduced behavioral effects of amphetamine and apomorphine and reduced in vivo brain binding of [3H]spiroperidol.

Authors:  N Rowland; J N Joyce; L L Bellush
Journal:  Behav Neurosci       Date:  1985-10       Impact factor: 1.912

9.  Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine.

Authors:  Jason M Williams; W Anthony Owens; Gregory H Turner; Christine Saunders; Concetta Dipace; Randy D Blakely; Charles P France; John C Gore; Lynette C Daws; Malcolm J Avison; Aurelio Galli
Journal:  PLoS Biol       Date:  2007-10-16       Impact factor: 8.029

10.  N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux.

Authors:  Habibeh Khoshbouei; Namita Sen; Bipasha Guptaroy; L 'Aurelle Johnson; David Lund; Margaret E Gnegy; Aurelio Galli; Jonathan A Javitch
Journal:  PLoS Biol       Date:  2004-03-16       Impact factor: 8.029

View more
  24 in total

1.  Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis.

Authors:  Sabrina D Robertson; Heinrich J G Matthies; W Anthony Owens; Vidiya Sathananthan; Nicole S Bibus Christianson; J Phillip Kennedy; Craig W Lindsley; Lynette C Daws; Aurelio Galli
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

2.  Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder.

Authors:  Erica Bowton; Christine Saunders; Kevin Erreger; Dhananjay Sakrikar; Heinrich J Matthies; Namita Sen; Tammy Jessen; Roger J Colbran; Marc G Caron; Jonathan A Javitch; Randy D Blakely; Aurelio Galli
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

3.  Akt-dependent and isoform-specific regulation of dopamine transporter cell surface expression.

Authors:  Nicole K Speed; Heinrich J G Matthies; J Phillip Kennedy; Roxanne A Vaughan; Jonathan A Javitch; Scott J Russo; Craig W Lindsley; Kevin Niswender; Aurelio Galli
Journal:  ACS Chem Neurosci       Date:  2010-05-25       Impact factor: 4.418

Review 4.  Insulin signaling and addiction.

Authors:  Lynette C Daws; Malcolm J Avison; Sabrina D Robertson; Kevin D Niswender; Aurelio Galli; Christine Saunders
Journal:  Neuropharmacology       Date:  2011-03-21       Impact factor: 5.250

5.  mTORC2/rictor signaling disrupts dopamine-dependent behaviors via defects in striatal dopamine neurotransmission.

Authors:  Olga I Dadalko; Michael Siuta; Amanda Poe; Kevin Erreger; Heinrich J G Matthies; Kevin Niswender; Aurelio Galli
Journal:  J Neurosci       Date:  2015-06-10       Impact factor: 6.167

6.  Amphetamine Reverses Escalated Cocaine Intake via Restoration of Dopamine Transporter Conformation.

Authors:  Cody A Siciliano; Kaustuv Saha; Erin S Calipari; Steve C Fordahl; Rong Chen; Habibeh Khoshbouei; Sara R Jones
Journal:  J Neurosci       Date:  2017-11-24       Impact factor: 6.167

Review 7.  Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.

Authors:  Daniel P Bermingham; Randy D Blakely
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

8.  Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex.

Authors:  Yan-Chun Li; Dong Xi; Joy Roman; Yue-Qiao Huang; Wen-Jun Gao
Journal:  J Neurosci       Date:  2009-12-09       Impact factor: 6.167

9.  High-Fat-Diet-Induced Deficits in Dopamine Terminal Function Are Reversed by Restoring Insulin Signaling.

Authors:  Steve C Fordahl; Sara R Jones
Journal:  ACS Chem Neurosci       Date:  2017-01-03       Impact factor: 4.418

10.  Phentermine induces conditioned rewarding effects via activation of the PI3K/Akt signaling pathway in the nucleus accumbens.

Authors:  Sa-Ik Hong; Min-Jung Kim; In-Jee You; Seung-Hwan Kwon; Shi-Xun Ma; Ji-Young Hwang; Jee-Yeon Seo; Yong-Hyun Ko; Bo Ram Lee; Seok-Yong Lee; Choon-Gon Jang
Journal:  Psychopharmacology (Berl)       Date:  2016-02-18       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.